A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.
Clinical trial NCT00309725 · COMPLETED
Trial details
- NCT number
- NCT00309725
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.